Using lung cancer screening CT scans to find COPD (MAP2)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort enrolls current and former smokers eligible for USPSTF lung cancer screening (age 50–80, ≥20 pack-years) who had a clinical screening CT at the University of Michigan within the past year. Investigators will analyze existing low-dose CT images for emphysema-like changes (for example, LAA>1%) and will verify COPD status using available or study-performed spirometry (FEV1/FVC ≤0.70). Eligible participants include those with a prior COPD diagnosis, prior obstructive spirometry, or CT evidence of emphysema, and the study links imaging and pulmonary function data to characterize COPD detection by CT. The cohort may also be contacted for future ancillary studies, including possible interventional trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Eligible for lung cancer screening by USPSTF 2021 criteria including age 50-80 years and currently or formerly smoking with at last 20 pack-years of smoking history at the time of consent.
* Willingness to participate in an observational clinical trial and to be contacted about future ancillary studies that could include interventional clinical trials.
* Ability to tolerate study procedures.
* Ability to provide informed consent.
* Clinical Lung Cancer Screening CT performed at the University of Michigan within the last year
* Meets one of the three following criteria:

  1. Prior Diagnosis of COPD in the EMR
  2. Prior pulmonary function meeting criteria for COPD (FEV1/FVC ≤ 0.70) or
  3. LAA\>1% on lung cancer screening CT scan

Exclusion Criteria:

* The presence of a respiratory condition other than COPD or asthma, or of a comorbid condition that in the judgment of the investigator may be the principal cause of respiratory symptoms (e.g. dyspnea or decreased exercise tolerance).
* Severe asthma, which is defined as any of the following:

Current (i.e. at the time of the visit) GINA Step 4 or higher therapy (medium dose ICS/LABA or high dose ICS or add-on LAMA; Medium dose = \>250 fluticasone propionate =100 fluticasone furoate, \>200 beclomethasone, \>400 budesonide, \>220 mometasone). The investigators will accept low-dose ICS/LABA or medium dose ICS.

or 3 or more unscheduled healthcare visits (provider/urgent care/ER) for asthma in the past 12 months or One asthma hospitalization in the past 12 months

* Concurrent participation in a therapeutic trial where treatment is blinded.
* Active pregnancy. Documentation of birth control will be required for pre-menopausal women.
* Cognitive dysfunction that prevents the participant from completing study procedures.
* BMI \> 35 kg/m2 at baseline, due to the effects of body weight on CT scan quality.
* Current illicit substance abuse, including cannabis smoking.
* Any illness expected to cause mortality in the next 3 years.
* Any implanted metallic devices or prosthesis above the waist that could degrade thoracic CT scan quality.
* History of thoracic radiation or thoracic surgery with resection of lung tissue.

Additional temporal exclusion criteria are as follows:

* Participants who present with an acute exacerbation of COPD, either solely participant-identified or that has been clinically treated, in the last 30 days can be rescreened for the study once the 30-day window from end of drug therapy has passed.
* Participants who present with current use of acute antibiotics or steroids can be rescreened for the study ≥30 days after discontinuing acute antibiotics/steroids. This restriction does not apply to participants who are on chronic prednisone therapy of \<10 mg per day or \<20 mg every other day or participants who are currently on chronic, prophylactic, or suppressive antibiotic therapy.

Where it's running

• University of Michigan
  Ann Arbor, Michigan, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enhanced COPD care for people being checked for lung cancer

  This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.

  Recruiting Region of Southern Denmark · Vejle · NCT07543601

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia

  This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.

  Recruiting Mansoura University · Al Mansurah, Dakahlia Governorate · NCT07854210

• Risk-based lung cancer screening in COPD patients using ML and clinical models

  This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.

  Recruiting Vejle Hospital · Vejle, Region Syddanmark · NCT07848815

• Biologics for Type 2 Inflammation in Asthma and COPD in Real World

  This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07823842

• Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers

  This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.

  Recruiting at 2 sites Phase 4 COPD Foundation · Saint Charles, Missouri and 1 other locations · NCT07816835

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.